| | Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients☆Received 28 December 2004; received in revised form 31 May 2005; accepted 1 June 2005. Abstract ObjectiveTo compare the efficacy of two atypical antipsychotic drugs, olanzapine and risperidone, in schizophrenic patients with post-psychotic depression. ResultsA clinically significant decrease of MADRS scores occurred in patients treated with both drugs for 8 weeks. ConclusionAtypical antipsychotic drugs may be particularly appropriate when treating schizophrenic patients with depression. a Department of psychiatry, Centre Esquirol, Centre Hospitalier et Universitaire, avenue de la Côte de Nacre, Caen, 14000, France b Lilly France, Neuroscience department, 13 rue Pagès, 92158 Suresnes Cedex, France  Corresponding author. Tel.: +33 2 31 06 50 18; fax: +33 2 31 06 49 87.
☆ This paper was presented at the 12th Association of European Psychiatry Congress, Geneva, April 15–18th, 2004. PII: S0920-9964(05)00234-3 doi:10.1016/j.schres.2005.06.001 © 2005 Elsevier B.V. All rights reserved. | |
|
|
ABSTRACT